| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression. | Gastroenterology | 2008 | 1.69 |
| 2 | alphav beta 3 and alphav beta 5 integrin antagonists inhibit angiogenesis in vitro. | Angiogenesis | 2003 | 1.48 |
| 3 | RGD-peptides for tissue engineering of articular cartilage. | Biomaterials | 2002 | 0.93 |
| 4 | Antiangiogenic combination tumor therapy blocking alpha(v)-integrins and VEGF-receptor-2 increases therapeutic effects in vivo. | Int J Cancer | 2006 | 0.87 |
| 5 | The effect of cyclo-DfKRG peptide immobilization on titanium on the adhesion and differentiation of human osteoprogenitor cells. | Biomaterials | 2005 | 0.81 |
| 6 | Small-molecule cyclic alpha V beta 3 antagonists inhibit sickle red cell adhesion to vascular endothelium and vasoocclusion. | Am J Physiol Heart Circ Physiol | 2007 | 0.81 |